缺氧誘導因子脯胺酸羥化酶 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "缺氧誘導因子脯胺酸羥化酶" in Chinese language version.

refsWebsite

Global rank Chinese rank

9nih.gov

4^th place

5^th place

9doi.org

2^nd place

23^rd place

1archive.org

6^th place

4^th place

archive.org

Warnecke, C.; Griethe, W.; Weidemann, A.; Jurgensen, J. S.; Willam, C.; Bachmann, S.; Ivashchenko, Y.; Wagner, I.; Frei, U. Activation of the hypoxia-inducible factor pathway and stimulation of angiogenesis by application of prolyl hydroxylase inhibitors. The FASEB Journal. 2003, 17 (9): 1186–8. PMID 12709400. doi:10.1096/fj.02-1062fje.

doi.org

Bacon, N. C.; Wappner, P; O'Rourke, J. F.; Bartlett, S. M.; Shilo, B; Pugh, C. W.; Ratcliffe, P. J. Regulation of the Drosophila bHLH-PAS protein Sima by hypoxia: Functional evidence for homology with mammalian HIF-1 alpha. Biochemical and Biophysical Research Communications. 1998, 249 (3): 811–6. PMID 9731218. doi:10.1006/bbrc.1998.9234.
Smith, T. G.; Robbins, P. A.; Ratcliffe, P. J. The human side of hypoxia-inducible factor. British Journal of Haematology. 2008, 141 (3): 325–34. PMC 2408651 . PMID 18410568. doi:10.1111/j.1365-2141.2008.07029.x.
Bruick, R. K. A Conserved Family of Prolyl-4-Hydroxylases That Modify HIF. Science. 2001, 294 (5545): 1337–40. PMID 11598268. doi:10.1126/science.1066373.
Karuppagounder, S. S.; Ratan, R. R. Hypoxia-inducible factor prolyl hydroxylase inhibition: Robust new target or another big bust for stroke therapeutics?. Journal of Cerebral Blood Flow & Metabolism. 2012, 32 (7): 1347–1361. PMC 3390817 . PMID 22415525. doi:10.1038/jcbfm.2012.28.
Warnecke, C.; Griethe, W.; Weidemann, A.; Jurgensen, J. S.; Willam, C.; Bachmann, S.; Ivashchenko, Y.; Wagner, I.; Frei, U. Activation of the hypoxia-inducible factor pathway and stimulation of angiogenesis by application of prolyl hydroxylase inhibitors. The FASEB Journal. 2003, 17 (9): 1186–8. PMID 12709400. doi:10.1096/fj.02-1062fje.
Selvaraju, V; Parinandi, N. L.; Adluri, R. S.; Goldman, J. W.; Hussain, N; Sanchez, J. A.; Maulik, N. Molecular Mechanisms of Action and Therapeutic Uses of Pharmacological Inhibitors of HIF-Prolyl 4-Hydroxylases for Treatment of Ischemic Diseases. Antioxidants & Redox Signaling. 2013, 20 (16): 2631–2665. PMC 4026215 . PMID 23992027. doi:10.1089/ars.2013.5186.
Muchnik, E; Kaplan, J. HIF prolyl hydroxylase inhibitors for anemia. Expert Opinion on Investigational Drugs. 2011, 20 (5): 645–56. PMID 21406036. doi:10.1517/13543784.2011.566861.
Chowdhury, Rasheduzzaman; Leung, Ivanhoe K. H.; Tian, Ya-Min; Abboud, Martine I.; Ge, Wei; Domene, Carmen; Cantrelle, François-Xavier; Landrieu, Isabelle; Hardy, Adam P. Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases. Nature Communications. 2016-08-26, 7: 12673. PMC 5007464 . PMID 27561929. doi:10.1038/ncomms12673 （英语）.
Berra E, Benizri E, Ginouvès A, Volmat V, Roux D, Pouysségur J. HIF prolylhydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia. EMBO J. Aug 2003, 22 (16): 4082–4090. PMC 175782 . PMID 12912907. doi:10.1093/emboj/cdg392.

nih.gov

ncbi.nlm.nih.gov

Bacon, N. C.; Wappner, P; O'Rourke, J. F.; Bartlett, S. M.; Shilo, B; Pugh, C. W.; Ratcliffe, P. J. Regulation of the Drosophila bHLH-PAS protein Sima by hypoxia: Functional evidence for homology with mammalian HIF-1 alpha. Biochemical and Biophysical Research Communications. 1998, 249 (3): 811–6. PMID 9731218. doi:10.1006/bbrc.1998.9234.
Smith, T. G.; Robbins, P. A.; Ratcliffe, P. J. The human side of hypoxia-inducible factor. British Journal of Haematology. 2008, 141 (3): 325–34. PMC 2408651 . PMID 18410568. doi:10.1111/j.1365-2141.2008.07029.x.
Bruick, R. K. A Conserved Family of Prolyl-4-Hydroxylases That Modify HIF. Science. 2001, 294 (5545): 1337–40. PMID 11598268. doi:10.1126/science.1066373.
Karuppagounder, S. S.; Ratan, R. R. Hypoxia-inducible factor prolyl hydroxylase inhibition: Robust new target or another big bust for stroke therapeutics?. Journal of Cerebral Blood Flow & Metabolism. 2012, 32 (7): 1347–1361. PMC 3390817 . PMID 22415525. doi:10.1038/jcbfm.2012.28.
Warnecke, C.; Griethe, W.; Weidemann, A.; Jurgensen, J. S.; Willam, C.; Bachmann, S.; Ivashchenko, Y.; Wagner, I.; Frei, U. Activation of the hypoxia-inducible factor pathway and stimulation of angiogenesis by application of prolyl hydroxylase inhibitors. The FASEB Journal. 2003, 17 (9): 1186–8. PMID 12709400. doi:10.1096/fj.02-1062fje.
Selvaraju, V; Parinandi, N. L.; Adluri, R. S.; Goldman, J. W.; Hussain, N; Sanchez, J. A.; Maulik, N. Molecular Mechanisms of Action and Therapeutic Uses of Pharmacological Inhibitors of HIF-Prolyl 4-Hydroxylases for Treatment of Ischemic Diseases. Antioxidants & Redox Signaling. 2013, 20 (16): 2631–2665. PMC 4026215 . PMID 23992027. doi:10.1089/ars.2013.5186.
Muchnik, E; Kaplan, J. HIF prolyl hydroxylase inhibitors for anemia. Expert Opinion on Investigational Drugs. 2011, 20 (5): 645–56. PMID 21406036. doi:10.1517/13543784.2011.566861.
Chowdhury, Rasheduzzaman; Leung, Ivanhoe K. H.; Tian, Ya-Min; Abboud, Martine I.; Ge, Wei; Domene, Carmen; Cantrelle, François-Xavier; Landrieu, Isabelle; Hardy, Adam P. Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases. Nature Communications. 2016-08-26, 7: 12673. PMC 5007464 . PMID 27561929. doi:10.1038/ncomms12673 （英语）.
Berra E, Benizri E, Ginouvès A, Volmat V, Roux D, Pouysségur J. HIF prolylhydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia. EMBO J. Aug 2003, 22 (16): 4082–4090. PMC 175782 . PMID 12912907. doi:10.1093/emboj/cdg392.